Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.
Healthcare HR professionals—if they haven’t already—must reshape the workplace each and every day by focusing intently and with new eyes on what matters most during this ongoing pandemic: employees.
As payer and provider organizations look to improve health outcomes around the far-reaching impacts of the pandemic, they must consider the unique needs of some of our most vulnerable populations, such as new and expecting mothers and their infants.
In the consolidated PBM industry, smaller companies say they can be nimble and not driven by rebates. But are they acquisition targets?
Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.
People with MS who are at risk for joblessness have poorer health-related habits and lower “locus of control” scores, according to findings by Kessler Foundation researcher Lauren Strober.
Gilead's Veklury gets full approval; AstraZeneca's Tagrisso heads toward second indication in NSCLC; another use for experimental antifungal therapy.
Quality impacts health outcomes. But do in-person quality measures meaningfully translate to telemedicine? Do the same measures that predict a doctor’s ability to deliver excellent in-person care also predict if s/he is a good “virtualist?”
The legislation follows an investigation that highlighted how minorities experience much higher rates of lower limb amputation than whites.
Study found that while frequency of cancer among people with multiple sclerosis (MS) increased over time, the overall cancer risk is similar between patients with MS and the general population.
The more we rely on technology, the further away we get from focusing on and addressing one of the most critical components of care: Trust between the patient and doctor.
Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.
Suppliers of personal protective equipment have come up with innovative ways to meet the demand, but one expert notes the lack of rigorous research into its efficacy.
“Lung cancer screening is a great example of the problem,” says the former chief medical and scientific officer for the American Cancer Society in this third of four-part video series.
The debate is scheduled to run from 9-10:30 p.m. ET. COVID-19 (but not healthcare) is one of the six topics that will be covered.
Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.
This week, Briana Contreras of Managed Healthcare Executive spoke with Doctors Art Papier and Nada Elbuluk of VisualDx. Art is a practicing dermatologist and associate professor of dermatology and medical informatics at University of Rochester, as well as the CEO of VisualDx. Nada is also a dermatologist in Los Angeles and she is Director of Clinical Impact for VisualDx. The three discussed how providers can leverage health IT to reduce cognitive bias and racial disparities in healthcare.
Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.
Rather than stopping hydroxychloroquine altogether, doses could be reduced and patients monitored if there are signs of retinopathy, say the authors of a commentary in the American Journal of Ophthalmology.
Study shows 12% retained sight for driving and 15% for reading.
Across the world, almost everyone has experienced a bad headache and knows the unpleasant symptoms that can come with it. Many have also faced migraines, which can cause dizziness, nausea and stomach pain - as well as impacting your vision.
In order to navigate the new landscape COVID-19 has brought along with it and connect with consumers who may be feeling confused and stressed out, lesser-known health insurers will need to introduce themselves to this new audience.
What does it mean? When did it begin? How is it different from public health? Here are the answers to these questions and more.
"Primary care as we know it today stands in the crosshairs, with new entrants vying for the hearts of consumers," says Forrester Research report. Telehealth and retail health clinics are among the suitors.
Pfizer, Moderna executives say efficacy, safety data won't be ready till well after Election Day. FDA's COVID-19 vaccine meeting on Thursday says sure to draw a big crowd.
William Trombatt and James Adams of AllianceRx Walgreens Prime discussed specialty pharmacy for people with MS at PBMI Specialty Rx Forum last week. The need for "higher touch" programs is important for people with MS, said Adams.
Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.
Venclexta was previously granted provisional approval by FDA in late 2018.
The pharma maker plans to apply for FDA Emergency Use Authorization for the vaccine after the third week of November.
Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.
